Biopharming and the Future of Healthcare

Your future medication may be grown inside a goat. 

Malnutrition is a serious problem in the developing world. A lack vitamin-A for instance affects millions, mostly populations in Africa and Southeast Asia. Delivering a supplement to each person would be impractical and costly. Thanks to genetic engineering, scientists have now created golden rice. This is much like the rice these populations already eat, only it contains beta-carotene—the precursor to vitamin-A, potentially saving millions from ill health. This is only one of the many developments in an exciting new field known as biopharming, a process that uses genetic engineering to turn plants and animals into factories for the production of commercial or medical compounds. It is not to be confused with bio-farming or organic farming.

A plant or animal with genetic material not originally its own is called transgenic. DNA may be modified within a species, or genes may be transplanted from one species to another, resulting in a desired effect. This is a way of creating a lot of a highly desired substance at low cost. For instance, crops such as tomatoes, corn, and tobacco are now being used to produce high-grade, and highly sought after pharmaceuticals. Transgenic plants can also be modified for environmental purposes, such as removing toxins from polluted water or soil.

Biopharming is now an intrinsic part of agriculture. It seeks to improve the quality, shelf life, and nutritional value of food, while helping crops become pest-resistant, drought-resistant, and carry other desirable qualities. Genetically modified organisms (GMOs) are transgenic crops used for commercial purposes. Mass production of such food reduces costs.

It’s not all hard uses of course. There are whimsical possibilities as well. For instance, Suntory— a Japanese firm has created blue roses, which have been genetically modified using pansy genes. Modified microorganisms such as bacteria, fungi, and yeast are being used to create an enzyme used in cheese making. Historically, an element found in a cow stomach called rennet has been used to clot cheese. But since the demand for hard cheeses has surpassed all available rennet, another method was required to meet demand. The enzyme, called chymosin is popular among cheese makers today.

Animals are being used in biopharming too. Cows have been imbued with the ability to produce human antibodies. Once the animal is produced, collecting and purifying those antibodies is an inexpensive process. Insulin and other drugs based on human proteins are good candidates for biopharming as well, within animals. Goats too are getting into the act. There are goats that produce human antithrombin (ATryn), used to treat a rare blood disorder. This process has recently been FDA approved. On the commercial side, goats have been genetically modified to produce spider silk within their milk, the strongest material in the world. It will be used in bulletproof vests, and in medicine, to create artificial tendons.

Today, the methods used to biopharm have a low success rate. In the future, when more reliable methods are worked out, researchers can use biopharming widely to produce drugs, antibodies, or vaccines. They can also produce biologics that are inexpensive, and even test new drugs without putting human subjects in harm’s way. One thing scientists are developing now are edible vaccines. For instance, vaccine carrying bananas are thought to be the perfect delivery method for children, particularly those in the developing world.

With GMO crops, there is some fear that they have been under-regulated, which could lead to unknown problems in human health, food production, or the environment. But GMOs have become so intertwined within our agricultural and food production systems that it is almost impossible to parse them out, especially when it comes to the ingredients of processed foods. Even so, the state of Vermont is currently being sued by agricultural giant Monsanto for forcing all GMO products to carry a label.

In medicine, some biotech firms say the opposite is true. Regulators are risk-averse when it comes to drugs produced through biopharming techniques. Even so, with a possible cure for Ebola and other serious illnesses being offered, biopharming is expected to become a normal fixture in medical science. Meanwhile, the medical establishment and regulatory superstructure must learn how best to accommodate it, utilize its offerings, and safeguard against possible hazards.

To learn more about so-called “spider goats” click here: 

​There are two kinds of failure – but only one is honorable

Malcolm Gladwell teaches "Get over yourself and get to work" for Big Think Edge.

Big Think Edge
  • Learn to recognize failure and know the big difference between panicking and choking.
  • At Big Think Edge, Malcolm Gladwell teaches how to check your inner critic and get clear on what failure is.
  • Subscribe to Big Think Edge before we launch on March 30 to get 20% off monthly and annual memberships.
Keep reading Show less

Why the ocean you know and love won’t exist in 50 years

Can sensitive coral reefs survive another human generation?

  • Coral reefs may not be able to survive another human decade because of the environmental stress we have placed on them, says author David Wallace-Wells. He posits that without meaningful changes to policies, the trend of them dying out, even in light of recent advances, will continue.
  • The World Wildlife Fund says that 60 percent of all vertebrate mammals have died since just 1970. On top of this, recent studies suggest that insect populations may have fallen by as much as 75 percent over the last few decades.
  • If it were not for our oceans, the planet would probably be already several degrees warmer than it is today due to the emissions we've expelled into the atmosphere.
Keep reading Show less
Image source: Topical Press Agency / Getty Images
Politics & Current Affairs
  • Though we know today that his policies eventually ended the Great Depression, FDR's election was seen as disastrous by some.
  • A group of wealthy bankers decided to take things into their own hands; they plotted a coup against FDR, hoping to install a fascist dictator in its stead.
  • Ultimately, the coup was brought to light by General Smedley Butler and squashed before it could get off the ground.
Keep reading Show less

Health care: Information tech must catch up to medical marvels

Michael Dowling, Northwell Health's CEO, believes we're entering the age of smart medicine.

Photo: Tom Werner / Getty Images
Sponsored by Northwell Health
  • The United States health care system has much room for improvement, and big tech may be laying the foundation for those improvements.
  • Technological progress in medicine is coming from two fronts: medical technology and information technology.
  • As information technology develops, patients will become active participants in their health care, and value-based care may become a reality.
Keep reading Show less